Home
About
Overview
Sharing Data
ORCID
Help
History (26)
Gender Bias Affects Assessment of Frailty and Recommendations for Surgery.
Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas.
Sperm Capacitation
Cognitive impairment and chemotherapy: a brief overview.
SOX9: The master regulator of cell fate in breast cancer.
See All 26 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
SOX9: The master regulator of cell fate in breast cancer.
SOX9: The master regulator of cell fate in breast cancer. Biochem Pharmacol. 2020 04; 174:113789.
View in:
PubMed
subject areas
Apoptosis
Breast Neoplasms
Cell Proliferation
Disease Progression
Drug Resistance, Neoplasm
Epigenesis, Genetic
Female
Humans
MicroRNAs
Neoplastic Stem Cells
Neovascularization, Pathologic
RNA Processing, Post-Transcriptional
RNA, Long Noncoding
SOX9 Transcription Factor
authors with profiles
Ravi Salgia